Decheng Capital LLC Diversified Active

CIK: 0002010850 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $326,315 (100.0% shares, 0.0% debt)

Holdings (24)

CGON CG ONCOLOGY INC 52.8%
Value ($000) $172,335 Shares 5,458,810 Est. Cost $40.84 Unrealized -15.1%
NUVB Nuvation Bio Inc. 6.2%
Value ($000) $20,295 Shares 6,950,239 Est. Cost $3.05 Unrealized 0.0%
RCUS Arcus Biosciences, Inc 4.1%
Value ($000) $13,247 Shares 869,790 Est. Cost $15.98 Unrealized +1.0%
ZNTL Zentalis Pharmaceuticals Inc. 3.8%
Value ($000) $12,558 Shares 3,070,442 Est. Cost $13.51 Unrealized -17.3%
KRYS KRYSTAL BIOTECH INC 3.7%
Value ($000) $12,078 Shares 65,772 Est. Cost $110.89 Unrealized +51.4%
BYSI BeyondSpring Inc. 3.6%
Value ($000) $11,900 Shares 4,958,143 Est. Cost $0.92 Unrealized +170.3%
ILMN Illumnia, Inc. 3.5%
Value ($000) $11,353 Shares 108,767 Est. Cost $122.34 Unrealized -8.3%
MERUS NV 3.2%
Value ($000) $10,597 Shares 179,098 Est. Cost $51.13 Unrealized
PHAT PHATHOM PHARMACEUTICALS INC 2.7%
Value ($000) $8,755 Shares 850,000 Est. Cost $8.62 Unrealized +19.5%
NAMS NEWAMSTERDAM PHARMA CO NV 2.4%
Value ($000) $7,684 Shares 400,000 Est. Cost $20.06 Unrealized 0.0%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 2.2%
Value ($000) $7,325 Shares 166,600 Est. Cost $50.23 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 2.2%
Value ($000) $7,301 Shares 347,835 Est. Cost $25.51 Unrealized -1.7%
CRNX CRINETICS PHARMACEUTICALS IN 2.2%
Value ($000) $7,075 Shares 157,958 Est. Cost $39.13 Unrealized +18.0%
CYTK CYTOKINETICS INC 1.6%
Value ($000) $5,095 Shares 94,043 Est. Cost $77.34 Unrealized -22.0%
LEGN LEGEND BIOTECH CORP-ADR 1.3%
Value ($000) $4,365 Shares 98,558 Est. Cost $54.63 Unrealized
AURA Aura Biosciences, Inc. 1.2%
Value ($000) $3,898 Shares 515,555 Est. Cost $8.47 Unrealized -13.5%
EQ Equillium Inc. 0.9%
Value ($000) $3,083 Shares 4,447,308 Est. Cost $0.59 Unrealized +140.2%
WGS GeneDx Holdings Corp. 0.8%
Value ($000) $2,708 Shares 103,604 Est. Cost $2.33 Unrealized +715.0%
VERA VERA THERAPEUTICS INC 0.8%
Value ($000) $2,524 Shares 69,767 Est. Cost $39.67 Unrealized 0.0%
PYXS Pyxis Oncology, Inc (formerly Apexigen) 0.3%
Value ($000) $1,082 Shares 326,810 Est. Cost $1.71 Unrealized +145.5%
ATRC AtriCure Inc. 0.2%
Value ($000) $610 Shares 26,797 Est. Cost $37.19 Unrealized -37.9%
GRAL GRAIL INC 0.1%
Value ($000) $279 Shares 18,127 Est. Cost $16.22 Unrealized 0.0%
Nuvation Bio Inc. 0.0%
Value ($000) $103 Shares 646,057 Est. Cost $0.16 Unrealized
ACLX ARCELLX INC 0.0%
Value ($000) $65 Shares 1,177 Est. Cost $54.36 Unrealized 0.0%